Indian Pharma Industry

Inside the Scramble for India’s Post-Patent Semaglutide Market

One Goal, 50 Brands: Inside the Scramble for India’s Post-Patent Semaglutide Market

BY Shashank Bhatt

India’s Pharma Exports Cross $28 Bn Till Feb, Grow Over 5 Pc

Economy & Policy

India’s Pharma Exports Cross $28 Bn Till Feb, Grow Over 5 Pc

BY PTI

FreePik : Indian Pharma Sector Clocks $28 Bn Export by End of February in FY26

Economy & Policy

Indian Pharma Sector Clocks $28 Bn Export by End of February in FY26

BY PTI

Emcure Pharma Q3 Net Profit Rises 48% YoY at ₹231 Cr

Emcure Pharma Q3 Net Profit Rises 48% YoY at ₹231 Cr

BY PTI

Freepik : Biopharma SHAKTI to Cut Import Dependence, Open New Growth Path for Indian Pharma

Union Budget 2026

From Imports to Innovation: Biopharma SHAKTI Explained

BY Shristi Acharya

FreePik : Pharma Sector Steps into 2026 with Innovation

Eye on $500 Bn by 2047, Pharma Sector Steps into 2026 with Innovation on Agenda

BY PTI

Indian Prime Minister Narendra Modi and US President Donald Trump

Why Trump’s ‘Ambiguous’ 100% Tariff May Not Hurt Indian Pharma Cos

BY Vikash Tripathi

Advertisement

India’s pharmaceutical sector is embracing green innovation, renewable energy and sustainable practices to lead the way toward a climate-resilient future.

How Indian Pharma Is Building a Sustainability Framework for a Greener Future

BY Ramesh Swaminathan

The Nifty Pharma index remained volatile through the session on May 12

Trump’s Drug Price-Cut Plans Send Indian Pharma into Wait-and-Watch Mode

BY Vaibhavi Ranjan

Pharma sector

Gland Pharma To Invest Rs 400 Crore To Expand Its Telangana Plant

BY PTI

Sun Pharma To Acquire Concert Pharmaceuticals In $576 Million Deal

Sun Pharma To Acquire Concert Pharmaceuticals In $576 Million Deal

BY Press Trust of India

Pharma sector

Allegations Of Death By Indian Cough Syrups May Kill Indian Pharma Sector

BY Outlook Business Desk

Pharma sector

Dr Reddy's, Sun Pharma Recall Products In US For Manufacturing Issues

BY Press Trust of India

Indian Pharma Industry May Rebound To 8-11% Growth Rate: Alkem

Indian Pharma Industry May Rebound To 8-11% Growth Rate: Alkem

BY Press Trust of India

Advertisement

Outlook Description : Outlook Image

What does Rakesh Jhunjhunwala see in Jubilant Life Sciences?

BY Himanshu Kakkar

Outlook Description : Outlook Image

How Biocon has been leading from the front | Editor's Note

BY N. Mahalakshmi